Increased Stable Retroviral Gene Transfer in Early Hematopoietic Progenitors Released from Quiescence
- 20 January 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (2), 207-213
- https://doi.org/10.1089/hum.1996.7.2-207
Abstract
It has been previously demonstrated that prestimulation with cytokines could improve gene transfer in hematopoietic progenitors. However, we have shown that no combination of cytokines so far tested is able to release rapidly in vitro the stem cell compartment from quiescence unless an autocrine transforming growth factor-β1 (TGF-β1) is blocked by specific oligonucleotide antisense or antiserum (Hatzfeld et al., 1991, J. Exp. Med., 174, 925). We now report that a 10-hr cytokine prestimulation of SBA¯CD34high human umbilical cord blood progenitors increases retrovirally mediated transfer of the nls-lacZ reporter gene from 1% to 23.8% and addition of anti-TGF-β serum doubles this increase (47.3%). Interestingly, the effect of anti-TGF-β preincubation on gene transfer is most effective on the most immature progenitors, which develop into high proliferative potential mixed colonies with 1–2 × 105 cells. Anti-TGF-β serum pretreatment increases gene transfer in these early colony-forming units granulocyte-erythroid-megakaryocyte-macrophage (CFU-GEMM) from 54.1% to 93.3%. It augments significantly the stability of gene expression in all subpopulations of mixed colonies. Colonies obtained after pretreatment with anti-TGF-β serum are larger and the expression of the stably integrated recombinant provirus does not reduce their size. This prestimulation method provides a substantial improvement for gene transfer efficiency within the quiescent stem cell compartment that is responsible for long-term engraftment. We have shown that no combination of cytokines so far tested is able to release rapidly in vitro the stem cell compartment from quiescence unless autocrine transforming growth factor-β1 (TGF-β1) is blocked by specific oligonucleotide antisense or antiserum. We now report that a 10-hr cytokine prestimulation of SBA¯CD34high human umbilical cord blood progenitors increases retrovirally mediated transfer of the nls-lacZ reporter gene from 23.8% without anti-TGF-β serum to 47.3% in the presence of anti-TGF-β serum. This effect is greater on the most immature progenitors, the early colony-forming units granulocyte-erythroid-megakaryocyte-macrophage (CFU-GEMM) (93.3%). These results suggest a simple method to increase stable gene transfer in the quiescent stem cell compartment responsible for long-term engraftment.Keywords
This publication has 30 references indexed in Scilit:
- Retroviral Transfer of the nlsLacZ Gene into Human CD34+Cell Populations and into TF-1 Cells: Future Prospects in Gene TherapyHuman Gene Therapy, 1994
- High Efficiency Retroviral-Mediated Gene Transduction into CD34+Cells Purified from Peripheral Blood of Breast Cancer Patients Primed with Chemotherapy and Granulocyte-Macrophage Colony-Stimulating FactorHuman Gene Therapy, 1994
- Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease.The Journal of Experimental Medicine, 1993
- Growth of human umbilical-cord blood in longterm haemopoietic culturesThe Lancet, 1992
- Human gene therapy comes of ageNature, 1992
- Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides.The Journal of Experimental Medicine, 1991
- Comparison of the Effects of Growth Factors on Retroviral Vector-Mediated Gene Transfer and the Proliferative Status of Human Hematopoietic Progenitor CellsHuman Gene Therapy, 1990
- Colony‐forming cells with high proliferative potential (HPP‐CFC)The International Journal of Cell Cloning, 1990
- Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical SiblingNew England Journal of Medicine, 1989
- Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in cultureJournal of Cellular Physiology, 1989